Vaibhav Drugs Private Limited

Manufactures and sells drugs, incorporated in 1996, based in Andhra Pradesh.

1996 | Hyderabad-35, Andhra Pradesh (India) | Active
Last Updated:

Vaibhav Drugs Profile

Key Indicators

  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.50 M
  • Company Age 28 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 1.70 M
  • Revenue Growth -29.26%
  • Profit Growth -70.52%
  • Ebitda -50.15%
  • Net Worth 5.44%
  • Total Assets -18.64%

About Vaibhav Drugs

Vaibhav Drugs Private Limited (VDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 October 1996 and has a history of 28 years and six months. Its registered office is in Hyderabad-35, Andhra Pradesh.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.

The company has closed loans amounting to ₹1.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Alapati Rao and Alapati Sridevi serve as directors at the Company.

Company Details

  • Location Hyderabad-35, Andhra Pradesh
  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230AP1996PTC025387

  • Company No.

    025387

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    04 Oct 1996

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Vijayawada

Industry

Pharma
Company report

Vaibhav Drugs Private Limited

Explore comprehensive data for Vaibhav Drugs Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Vaibhav Drugs?

Board Members (2)

NameDesignationAppointment DateStatus
Alapati Rao Country flag representing In Director 24-May-2010Current
Alapati Sridevi Country flag representing In Director 30-May-2012Current

Financial Performance of Vaibhav Drugs.

Vaibhav Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 29.26% decrease. The company also saw a substantial fall in profitability, with a 70.52% decrease in profit. The company's net worth moved up by a moderate rise of 5.44%.

Vaibhav Drugs revenue growth over time
Vaibhav Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-29.26%
Revenue from Operations
-29.27%
Total Assets
-18.64%
Profit or Loss
-70.52%
Net Worth
5.44%
EBITDA
-50.15%

What is the Ownership and Shareholding Structure of Vaibhav Drugs?

In 2023, Vaibhav Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹1.70 M

Charges Breakdown by Lending Institutions

  • Deena Bank : 0.17 Cr

Latest Charge Details

DateLenderAmountStatus
16 Jun 1997Deena Bank₹1.70 MSatisfied

How Many Employees Work at Vaibhav Drugs?

Vaibhav Drugs has a workforce of 17 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Vaibhav Drugs Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vaibhav Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaibhav Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Vaibhav Drugs

Recent activity within the organization

  • Annual General Meeting

    Vaibhav Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Vaibhav Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.

  • Director Appointment

    Alapati Sridevi was appointed as a Director was appointed as a Director on 30 May 2012 & has been associated with this company since 12 years 11 months .

  • Director Appointment

    Alapati Naga Sankara Rao was appointed as a Director was appointed as a Director on 24 May 2010 & has been associated with this company since 14 years 11 months .

  • Charges

    A charge registered on 16 Jun 1997 via Charge ID 90134027 with Deena Bank was fully satisfied on 16 Feb 2009.

  • Charges

    A charge with Deena Bank of Rs. 1.70 M registered on 16 Jun 1997 with Charge ID 90134027 was modified on 20 Feb 2004.

Frequently asked questions

  • What is the Incorporation or founding date of Vaibhav Drugs Private Limited?

    Vaibhav Drugs Private Limited was incorporated on 04 Oct 1996.

  • What is authorized share capital and paid-up capital of Vaibhav Drugs Private Limited?

    The authorized share capital of Vaibhav Drugs Private Limited is ₹ 1.50 M and paid-up capital is ₹ 1.50 M.

  • Who are the current board members & directors of Vaibhav Drugs Private Limited?

    Currently 2 directors are associated with Vaibhav Drugs Private Limited.

    • Alapati Naga Sankara Rao
    • Alapati Sridevi

  • What is the registered address of Vaibhav Drugs Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Vaibhav Drugs Private Limited is 6-121/1 Peddamberpet, Hyderabad. Hyderabad. India, Hyderabad-35, Andhra Pradesh.

  • What is the corporate identification number (CIN) and company number of Vaibhav Drugs Private Limited?

    The corporate identification number (CIN) of Vaibhav Drugs Private Limited is U24230AP1996PTC025387 and the company number is 025387 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Vaibhav Drugs Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Vaibhav Drugs Private Limited has fallen by -29.26%.

  • How many employees does Vaibhav Drugs Private Limited currently have?

    As Per 2023 financial reports, 17 employees are currently employed by Vaibhav Drugs Private Limited.

  • What change has been observed in the net worth of Vaibhav Drugs Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Vaibhav Drugs Private Limited has experienced an upsurge of 5.44%.

  • When was the last Balance Sheet of Vaibhav Drugs Private Limited filed with the ROC?

    The most recent Balance Sheet for Vaibhav Drugs Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development